Showing results (1111-1120 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|January 21, 2020
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in uteroMalin Hedlund, Gudny Ella Thorlacius, Margarita Ivanchenko, et al.
RMD Open|January 21, 2020
Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspectiveGuillermo J Pons-Estel, Manuel Francisco Ugarte-Gil, Guillermina B Harvey, et al.
RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
RMD Open|January 6, 2022
Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysisRaphael Micheroli, Muriel Elhai, Sam Edalat, et al.
RMD Open|March 17, 2021
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicineWillem Lems, Maarten Boers, Ronald F van Vollenhoven, et al.
RMD Open|January 19, 2022
Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohortMarion Pons, Sylvie Chevret, Karine Briot, et al.
RMD Open|February 17, 2021
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre studyRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, et al.
RMD Open|February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trialMaria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
RMD Open|February 6, 2021
To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritisFabio Massimo Perrotta, Rik Lories, Ennio Lubrano
RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.
Pageof 197